Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. tissue specific
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Tissue Specific Articles & Analysis

44 news found

A New Mouse Model for SARS-CoV-2 Studies Beyond the Respiratory System

A New Mouse Model for SARS-CoV-2 Studies Beyond the Respiratory System

Five years since the onset of the COVID-19 pandemic, the scientific community delved deep into the mysteries of the SARS-CoV-2 virus, to understand its impact on our health and develop antiviral therapies and vaccine. We know that SARS-CoV-2 virus enters human cells primarily through the angiotensin-converting enzyme 2 (hACE2) receptor, which is abundant in various organs such as the lungs, ...

BySCIREQ - an emka TECHNOLOGIES Company


Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems   

Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems  

l Oral Thin Films: Fast dissolving method to make patient’s compliance easy by giving easy to use. l Microencapsulation Systems: Guarding actives and allowing for controlled release. l Nanoparticle Development: Solubility enhancement, tissue specificity to get best result from treatment. l Vesicular Systems Engineering: Liposomal and niosomal formulations ...

ByProtheragen-ING


CD Formulation: Nanoparticle Technology Heralds New Breakthroughs in Pharmaceutical Innovation   

CD Formulation: Nanoparticle Technology Heralds New Breakthroughs in Pharmaceutical Innovation  

This enables more accurate delivery of medications to specific tissues or organs, minimizing side effects while maximizing therapeutic efficacy. ...

ByCD Formulation


CD Formulation Launches Cutting-Edge Lipid-Based Nanoparticle Development Services for Drug Delivery

CD Formulation Launches Cutting-Edge Lipid-Based Nanoparticle Development Services for Drug Delivery

By offering precise and customizable development services, the company enables pharmaceutical manufacturers to optimize their formulations, ensuring that the active ingredients are delivered efficiently to the target tissues. This strategic focus on LNPs underscores CD Formulation's commitment to advancing medical science. ...

ByCD Formulation


CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

Each tissue microarray is constructed from paraffin-embedded (FFPE) tissue blocks from a specific number of donor cases. Additionally, the microarrays come in various configurations, with a range of cases and core numbers per case, allowing researchers to tailor their experiments to their specific needs. For example, the Multiple ...

ByCD BioSciences


CD Formulation Empowers High-volume Manufacturing of Microspheres

CD Formulation Empowers High-volume Manufacturing of Microspheres

By encapsulating active pharmaceutical ingredients (APIs) within these microspheres, drugs can be delivered directly to specific tissues or organs, resulting in improved therapeutic efficacy and reduced side effects. ...

ByCD Formulation


CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications

CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications

These drug delivery systems can enhance the interaction with biological materials and conjugate to specific target molecules to reach specific tissues or cells by modifying their surface properties. ...

ByCD Bioparticles


Amerigo Scientific Launches Cost-Effective GalNAc (TEG)-CPG Reagent to Empower Nucleic Acid Therapeutics

Amerigo Scientific Launches Cost-Effective GalNAc (TEG)-CPG Reagent to Empower Nucleic Acid Therapeutics

Asialoglycoprotein receptor (ASGPR) is the ideal target for the delivery of therapeutic oligonucleotides to the liver due to its tissue specificity, high expression levels, rapid internalization, and turnover. ...

ByAmerigo Scientific


BIO Investor Forum Company Snapshot: InvivoSciences

BIO Investor Forum Company Snapshot: InvivoSciences

IVS’s Functional 3D tissue models recapitulate the physiological properties of human cardiac, smooth and skeletal muscle and connective tissue. ...

ByInvivoSciences, Inc. (IVS)


1st MitraClip Procedure Guided by 4D Performed at UC Davis Health

1st MitraClip Procedure Guided by 4D Performed at UC Davis Health

The software platform uses standard medical images to create a digital twin of a patient, enabling doctors to experience it as a 4D interactive hologram, interacting with the patient’s organs and tissues as if they were actual, physical objects. This technology enables real-time accurate situational awareness of catheters and implantable devices in relation to complex ...

ByEchoPixel, Inc.


ITM Executes Option to In-license Targeted Radionuclide Therapy Candidate LuCaFab (ITM-31) for the Treatment of Malignant Brain Tumors

ITM Executes Option to In-license Targeted Radionuclide Therapy Candidate LuCaFab (ITM-31) for the Treatment of Malignant Brain Tumors

ITM-31 is a carbonic anhydrase XII (CA XII)-specific antibody Fab fragment developed by Helmholtz Munich and coupled with ITM's medical radioisotope, non-carrier-added Lutetium-177 (n.c.a. 177Lu, EndolucinBeta®). ...

ByITM Isotope Technologies Munich SE


INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market

INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market

EXO-NET is an immunoaffinity magnetic bead capture technology that uses a proprietary multi-antibody matrix coated on nanobeads to capture exosomes from multiple cells and tissues based on their surface markers. By changing the antibodies in the matrix, EXO-NET can be customised to capture exosomes released from specific cells and tissues for ...

ByINOVIQ Ltd


Profacgen Updated Its E3 Ligase and Target Proteins Development Services

Profacgen Updated Its E3 Ligase and Target Proteins Development Services

The majority of PROTACs were created with ligands that recruit E3 ligases, which are widely expressed in tumors and normal tissues, and these PROTACs can cause off-target toxicity if the target protein is not tumor-specific. The development of tumor-specific/selective PROTACs will benefit from identifying those E3 ligases that are enriched in ...

ByProfacgen


Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis

Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis

The Elucid platform is the only FDA-Cleared and CE-Marked software to objectively quantify plaque morphology validated against tissue specimens. Specifically, the exquisite algorithms developed through machine learning characterize tissue types in the artery wall known to cause heart attacks, such as lipid rich necrotic core. ...

ByElucid


Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

It is recommended to determine 50% cytotoxicity concentration (CC50) values in quiescent and to divide cells from various relevant human cell types and tissues to ascertain the potential for cell cycle, species, or tissue-specific toxicity. ...

ByCreative Diagnostics


New data show HOOKIPA’s arenaviral immunotherapies induce potent T cell responses in novel combinations and against tumor self-antigens

New data show HOOKIPA’s arenaviral immunotherapies induce potent T cell responses in novel combinations and against tumor self-antigens

Co-stimulatory agents, like 4-1BB agonists, are known as accelerators of cancer immunotherapy, because they help induce potent, tumor-specific T-cells that can infiltrate and kill tumors. The combination of an arenaviral immunotherapy with a 4-1BB agonistic antibody resulted in complete tumor rejection in 30 percent of mice following treatment. ...

ByHookipa Pharma Inc.


Announcement – New AI Tool for Prostate MRI Analysis to Support PI-RADS Scoring

Announcement – New AI Tool for Prostate MRI Analysis to Support PI-RADS Scoring

“MRI is an advanced imaging tool, specifically for soft tissue like the prostate gland, with potential for improvement using AI,” said Ron Soferman, CEO at RSIP Vision. ...

ByRSIP Vision


EchoPixel’s True3D Receives Medical Device Registration in Japan

EchoPixel’s True3D Receives Medical Device Registration in Japan

This first-of-its-kind software enables the entire heart surgical team to develop a precise personalized plan by interacting with specific organs and tissues as if they were actual physical objects. ...

ByEchoPixel, Inc.


Creative Proteomics's Targeted Metabolomic Platform Supports Ketone Body Detection

Creative Proteomics's Targeted Metabolomic Platform Supports Ketone Body Detection

Creative Proteomics offers targeted metabolomics services for the enrichment and accurate quantitative profiling of a specific metabolite in blood, urine or other body fluids and tissues under specific physiological or pathological conditions. ...

ByCreative Proteomics


CD Genomics RNA Diversifies Its RNA Service Portfolio by Adding Whole Transcriptome Sequencing

CD Genomics RNA Diversifies Its RNA Service Portfolio by Adding Whole Transcriptome Sequencing

Whole transcriptome refers to the sum of all RNA (transcripts) transcribed from a specific species, tissue or cell type under a certain period or condition, including mRNA and non-coding RNA (ncRNA). ...

ByCD Genomics

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT